​

AC Immune SA (ACIU) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

ACIU Stock Forecast

AC Immune SA (ACIU) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $10.00 and a low of $8.00. This represents a 324.53% increase from the last price of $2.12.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $10 Avg: $9 Low: $8 Last Closed Price: $2.12

ACIU Stock Rating

AC Immune SA stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

ACIU Price Target Upside V Benchmarks

TypeNameUpside
StockAC Immune SA324.53%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.12$2.12$2.12
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2513---4
May, 2513---4
Apr, 2513---4
Mar, 2513---4
Feb, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 30, 2024Thomas ShraderBTIG$8.00$3.97101.51%277.36%
Jul 11, 2022Leerink Partners$10.00$3.35198.51%371.70%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 18, 2024H.C. WainwrightBuyBuyhold
May 30, 2024BTIGBuyinitialise
Jul 11, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.86$-0.97$-0.85$-0.64-----
Avg Forecast$-0.83$-0.63$-0.88$-0.71$-0.54$-0.25$-0.24$0.62$0.85
High Forecast$-0.10$-0.08$-0.09$-0.63$-0.51$1.29$0.67$9.12$1.69
Low Forecast$-1.35$-1.03$-1.66$-0.78$-0.56$-2.75$-0.87$-7.66$-0.18
Surprise %3.61%53.97%-3.41%-9.86%-----

Revenue Forecast

$0 $80M $160M $240M $320M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.43M-$3.94M$14.80M-----
Avg Forecast$15.63M$28.25M$5.58M$10.19M$27.09M$56.96M$66.35M$172.18M$201.19M
High Forecast$23.22M$41.99M$9.44M$11.04M$27.74M$100.42M$69.18M$303.54M$354.67M
Low Forecast$5.10M$9.22M$1.72M$9.35M$26.57M$3.86M$63.51M$11.66M$13.62M
Surprise %-1.25%--29.53%45.19%-----

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.10M$-73.00M$-70.75M$-54.23M-----
Avg Forecast$-69.92M$-53.55M$-74.13M$-59.72M$-45.51M$-24.87M$-24.29M$11.46M$71.67M
High Forecast$-8.69M$-6.66M$-7.49M$-53.58M$-43.34M$109.58M$56.57M$772.66M$142.75M
Low Forecast$-114.11M$-87.40M$-140.66M$-65.87M$-47.67M$-232.52M$-74.05M$-648.74M$-15.19M
Surprise %-11.18%36.30%-4.56%-9.19%-----

ACIU Forecast FAQ

Is AC Immune SA stock a buy?

AC Immune SA stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AC Immune SA is a favorable investment for most analysts.

What is AC Immune SA's price target?

AC Immune SA's price target, set by 7 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $8 at the low end to $10 at the high end, suggesting a potential 324.53% change from the previous closing price of $2.12.

How does AC Immune SA stock forecast compare to its benchmarks?

AC Immune SA's stock forecast shows a 324.53% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for AC Immune SA over the past three months?

  • June 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is AC Immune SA’s EPS forecast?

AC Immune SA's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.54, marking a -15.62% decrease from the reported $-0.64 in 2023. Estimates for the following years are $-0.25 in 2025, $-0.24 in 2026, $0.62 in 2027, and $0.85 in 2028.

What is AC Immune SA’s revenue forecast?

AC Immune SA's average annual revenue forecast for its fiscal year ending in December 2024 is $27.09M, reflecting a 83.03% increase from the reported $14.8M in 2023. The forecast for 2025 is $56.96M, followed by $66.35M for 2026, $172.18M for 2027, and $201.19M for 2028.

What is AC Immune SA’s net income forecast?

AC Immune SA's net income forecast for the fiscal year ending in December 2024 stands at $-45.506M, representing a -16.09% decrease from the reported $-54.233M in 2023. Projections indicate $-24.874M in 2025, $-24.287M in 2026, $11.46M in 2027, and $71.67M in 2028.